Pfizer Hit With $73M Verdict In Menopause Drug Suit

Law360, New York (December 6, 2011, 10:58 PM EST) -- A Pennsylvania jury reportedly ordered Pfizer Inc. on Tuesday to pay $72.6 million in damages to three women who say they developed breast cancer after taking menopause drugs made by the company's Wyeth and Pharmacia & Upjohn subsidiaries.

The jury in the Philadelphia Court of Common Pleas awarded $20 million in compensatory damages to Susan Elfont, while Bernadette Kalenkoski received $27.85 million and Judy Mulderig received $24.75 million, according to Bloomberg News.

A spokesman for Pfizer said in a statement Tuesday that the final determination of...
To view the full article, register now.